The role of ATBF1 nuclear translocation in gastric and intestinal phenotype and chemosensitivity of gastric cancer

ATBF1核易位在胃癌胃、肠表型及化疗敏感性中的作用

基本信息

  • 批准号:
    18590693
  • 负责人:
  • 金额:
    $ 2.43万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2006
  • 资助国家:
    日本
  • 起止时间:
    2006 至 2007
  • 项目状态:
    已结题

项目摘要

Background and aims: MUC5AC belongs to the family of secreted mucins and expresses in foveolar cells of the stomach. Alterations of mucin expression take place in gastric cancer. It was reported that MUC5AC expression in gastric cancer correlates with poor prognosis. However, the transcriptional regulation mechanism of MUC5AC has not been well elucidated. AT motif binding factor 1 (ATBF1) is a homeotic transcription factor which negatively regulates Alpha-fetoprotein (AFP) and oncoprotein Myb. We have showed previously that ATBF1 negatively regulates transcription of brush-border enzyme gene, aminopeptidase-N and that the absence of ATBF1 is a distinct feature of AFP-producing gastric cancer cells, which are characterized by extremely high malignancy (Oncogene 2001). ATBF1 has recently been identified as a candidate of tumor suppressor for prostate cancer (Nat. Genet. 2005). In this study, we investigated the transcriptional regulation of MUC5AC by ATBF1.Materials and Methods: 1. We an … More alyzed ATBF1 and MUC5AC expression by immunohistochemistry in 123 area of 41 gastric cancers specimen. 2. We analyzed whether there is an AT motif in MUC5AC promoter region or not. 3. To analyze the transcriptional regulation of MUC5AC by ATBF1, we performed transient transfection and dual luciferase-reporter assay in MKN45 cells (gastric cancer cells). 4. To analyze the transcriptional regulation of MUC5AC by ATBF1 in protein level, we examined the protein expression of MUC5AC in MKN45 cells which was overexpressed ATBF1 using confocal microscopy. 5. To assess the binding of ATBF1 to the AT motif in MUC5AC promoter region, we performed chromatin immunoprecipitation (ChIP).Results: 1. Only 9% (3/33) of ATBF1-positive(nuclear staining) gastric cancers were MUC5AC positive, and, 76% (68/90) of ATBF1-negative (cytoplasm staining or no staining )gastric cancers were MUC5AC positive. ATBF1 nuclear staining tends to be observed in gastric cancer cells negative for MUC5AC (p<.0001). 2. We detected the AT motif in MUC5AC promoter region (-1646-1634). 3. Transient transfection and dual luciferase-reporter assay demonstrated that ATBF1 suppressed the activity of MUC5AC promoter (35 plus minus 1.1%). 4. 70. 7 plus minus 1.2% of MKN45 cells transfected with control were MUC5AC positice, however only 11.3 plus minus 3.1% of MKN45 cells transfected with ATBF1 were MUC5AC positive (p<.0001). Overexpressed ATBF1 suppressed MUC5AC endogeneous protein in gastric cancer cells. 5. ChIP revealed that ATBF1 binds AT motif of MUC5AC promoter.Conclusion: ATBF1 binds to AT motif of MUC5AC promoter and negatively regulates transcription of the MUC5AC gene in gastric cancer. Less
背景与目的:MUC 5AC属于分泌型粘蛋白家族,表达于胃小凹细胞。胃癌组织中粘蛋白的表达发生了改变。已有研究表明,胃癌组织中MUC 5AC的表达与预后不良有关。然而,MUC 5AC的转录调节机制尚未得到很好的阐明。AT基序结合因子1(AT motif binding factor 1,ATBF 1)是一种同源异型转录因子,负调控甲胎蛋白(AFP)和癌蛋白Myb。我们之前已经证明ATBF 1负调节刷状缘酶基因(氨基肽酶-N)的转录,并且ATBF 1的缺失是产生AFP的胃癌细胞的显著特征,其特征在于极高的恶性度(Oncogene 2001)。ATBF 1最近已被鉴定为前列腺癌的肿瘤抑制因子的候选者(Nat.Genet. 2005年)。本研究旨在探讨ATBF 1对MUC 5AC的转录调控作用。我们 ...更多信息 应用免疫组化方法检测41例胃癌标本中123个癌灶ATBF 1和MUC 5AC的表达。2.我们分析了MUC 5AC启动子区是否存在AT基序。3.为了分析ATBF 1对MUC 5AC的转录调控,我们在MKN 45细胞(胃癌细胞)中进行了瞬时转染和双报告基因检测。4.为了从蛋白水平分析ATBF 1对MUC 5AC的转录调控作用,我们利用共聚焦显微镜检测了过表达ATBF 1的MKN 45细胞中MUC 5AC的蛋白表达。5.采用染色质免疫沉淀法(ChIP)检测ATBF 1与MUC 5AC启动子区AT基序的结合情况。在ATBF 1阳性(核染色)的胃癌中,MUC 5AC阳性率仅为9%(3/33),而在ATBF 1阴性(胞浆染色或不染色)的胃癌中,MUC 5AC阳性率为76%(68/90)。ATBF 1核染色倾向于在MUC 5AC阴性的胃癌细胞中观察到(p<.0001)。2.在MUC 5AC启动子区(-1646-1634)检测到AT基序。3.瞬时转染和双酶报告基因检测表明ATBF 1抑制MUC 5AC启动子的活性(35 ± 1.1%)。4. 70.用对照转染的MKN 45细胞中7 ± 1.2%为MUC 5AC阳性,而用ATBF 1转染的MKN 45细胞中仅11.3 ± 3.1%为MUC 5AC阳性(p<0.0001)。过表达ATBF 1抑制胃癌细胞中MUC 5AC内源性蛋白。5.结论:胃癌组织中ATBF 1与MUC 5AC启动子AT基序结合,负调控MUC 5AC基因的转录。少

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
ATBF1 upregulates p21 transcription in cooperation with p53 and RUNX3
ATBF1 与 p53 和 RUNX3 合作上调 p21 转录
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mori Y;Kataoka H;Miura Y;et al.;Mori Y
  • 通讯作者:
    Mori Y
AT motif binding factor 1(ATBF1)upregulates p21 transcription in cooperation with p53 and RUNX3.
AT 基序结合因子 1 (ATBF1) 与 p53 和 RUNX3 协同上调 p21 转录。
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mori Y;Kataoka H;et. al.
  • 通讯作者:
    et. al.
Gastric phenotypic expression and histogenesis of metachronous gastric cancers endoscopically resected
内镜下切除的异时性胃癌的胃表型表达和组织发生
  • DOI:
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mizoshita T;Kataoka H;Tanida S;Sasaki M;Ogasawara N;Kubota E;Wada T;Yamada T;Mori Y;Shimura T;Tsukamoto T;Tatematsu M;Joh T
  • 通讯作者:
    Joh T
Subcellular localization of ATBF1 regulates MUC5AC transcription in gastric cancer
  • DOI:
    10.1002/ijc.22654
  • 发表时间:
    2007-07-15
  • 期刊:
  • 影响因子:
    6.4
  • 作者:
    Mori, Yoshinori;Kataoka, Hiromi;Joh, Takashi
  • 通讯作者:
    Joh, Takashi
AT motif binding factor 1 (ATBF1) upregulates p21 transcription in cooperation with p53 and RUNX3
AT 基序结合因子 1 (ATBF1) 与 p53 和 RUNX3 配合上调 p21 转录
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mori;Y.;Kataoka;H.;Wada;T.;Kubota;E.;Ogasawara;N.;Sasaki;M.;Kamiya;T.;Miura Y.;Joh;T
  • 通讯作者:
    T
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOH Takashi其他文献

JOH Takashi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOH Takashi', 18)}}的其他基金

To clarify the mechanism that C terminal fragments of EGFR ligand cause nuclear export of transcriptional repressors
阐明EGFR配体C端片段引起转录抑制子核输出的机制
  • 批准号:
    21590790
  • 财政年份:
    2009
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
EGFR ligands trafficking into the nucleus in gastric cancer cells
EGFR 配体转运至胃癌细胞的细胞核
  • 批准号:
    16590614
  • 财政年份:
    2004
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Negative regulation of Chk2 expression by p53
p53 对 Chk2 表达的负调控
  • 批准号:
    13670543
  • 财政年份:
    2001
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
MEMBRANE-BINDING COMPLEMENT REGULATORY FACTER IN GASTROINTESTINAL TRACT
胃肠道中的膜结合补体调节因子
  • 批准号:
    08670607
  • 财政年份:
    1996
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
DEVELOPMENT AND REPAIR OF MICRO-INJURY IN GASTRIC MUCOSA
胃粘膜微损伤的形成与修复
  • 批准号:
    06670570
  • 财政年份:
    1994
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

網羅的なCpG siteのDNAメチル化の検索による肺腺癌のtumor suppressor geneの同定
综合寻找CpG位点DNA甲基化鉴定肺腺癌抑癌基因
  • 批准号:
    23K08296
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Modeling Breast Cancer Associated with KMT2C as a Haploinsufficient and Recessive Tumor Suppressor Gene
与作为单倍体不足和隐性肿瘤抑制基因 KMT2C 相关的乳腺癌建模
  • 批准号:
    491638
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Miscellaneous Programs
Investigation of relationship between structural variety and function of tumor suppressor protein, p53
抑癌蛋白p53结构多样性与功能关系的研究
  • 批准号:
    23K05652
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Depletion of tumor suppressor miRNAs in blood relates to tumor progression and poor outcomes in esophageal cancer
血液中抑癌 miRNA 的消耗与食管癌的肿瘤进展和不良预后相关
  • 批准号:
    23K06700
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Modulation of cell proliferation by the tumor suppressor protein NRK
肿瘤抑制蛋白 NRK 对细胞增殖的调节
  • 批准号:
    23K08817
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Characterizing the role of tumor suppressor phase separation and chromatin organization in maintaining genomic integrity
表征肿瘤抑制相分离和染色质组织在维持基因组完整性中的作用
  • 批准号:
    10723739
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
Hydrogen sulfide functions as a tumor suppressor in glioblastoma
硫化氢在胶质母细胞瘤中充当肿瘤抑制剂
  • 批准号:
    10656703
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
PD-1 tumor suppressor mechanims in peripheral T-cell lymphoma
PD-1在外周T细胞淋巴瘤中的抑癌机制
  • 批准号:
    10581151
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
SELENOF is a Novel Tumor Suppressor and a New Target to Overcome Racial Disparity in Breast Cancer.
SELENOF 是一种新型肿瘤抑制剂,也是克服乳腺癌种族差异的新靶点。
  • 批准号:
    10735662
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
Does nuclear PTEN have tumor suppressor functions independent of phosphatase activities?
核 PTEN 是否具有独立于磷酸酶活性的肿瘤抑制功能?
  • 批准号:
    22K07035
  • 财政年份:
    2022
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了